MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, to be added as a commercial feature to the company’s Edge AI Intoxication Detection Kiosks. The fatigue detection module is designed for high-risk industries including aviation, road transport, and mining, complementing MindBio’s broader voice-based diagnostics platform aimed at identifying intoxication and neurological impairment. Initial commercial testing of the kiosk platform is expected in late second quarter 2026.
The expansion into fatigue detection underscores MindBio’s commitment to leveraging artificial intelligence for workplace safety. The company’s AI prediction model, which uses over 50 million data points, predicts alcohol intoxication with remarkable accuracy by analyzing the human voice. By integrating fatigue detection, the kiosks can identify a broader range of impairments that compromise safety in critical environments. The announcement highlights the growing potential of voice-based diagnostic tools in industrial settings, where real-time monitoring of employee alertness can prevent accidents and save lives.
MindBio is commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The enterprise platform includes Edge-AI kiosks with bespoke hardware and software for detecting drug and alcohol intoxication using the human voice and AI. The platform targets industries such as mining, aviation, construction, and law enforcement. The addition of fatigue detection technology enhances the platform’s utility, offering employers a non-invasive, rapid screening method for multiple impairment types.
The company’s focus on high-risk sectors is significant, as fatigue is a leading cause of accidents in transportation and heavy industries. According to the National Safety Council, drowsy driving alone causes thousands of crashes annually. MindBio’s technology could provide a proactive solution, allowing companies to identify fatigued workers before they engage in safety-critical tasks. The voice-based approach offers advantages over traditional methods, such as breathalyzers or fitness-for-duty tests, by being contactless and quick to administer.
The development aligns with broader trends in workplace safety technology, where AI and edge computing are enabling real-time risk assessment. MindBio’s kiosks process voice data locally on-device, ensuring privacy and low latency. The company’s technology has been validated through extensive data analysis, with the AI model trained on millions of voice samples to detect subtle changes associated with impairment. The expansion into fatigue detection builds on this foundation, leveraging the same core voice analysis capabilities.
For investors, the announcement signals MindBio’s progress in commercializing its technology platform. The company’s newsroom at https://nnw.fm/MBQIF provides updates on OTCQB ticker MBQIF. The full press release is available at https://nnw.fm/WWgcb. As MindBio moves toward commercial testing, the implications for workplace safety and the voice AI market are substantial, with potential applications extending to other industries and impairment types.
